Showing results (941-950 of 1,038) with videos related to
Sort By:
Pageof 104
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2013
Phase II trial of MEK inhibitor selumetinib (AZD6244, ARRY-142886) in patients with BRAFV600E/K-mutated melanomaFederica Catalanotti, David B Solit, Melissa P Pulitzer, et al.Frontiers in Oncology|October 17, 2022
Intermittent MEK inhibition for the treatment of metastatic uveal melanomaShaheer Khan, Sapna P Patel, Alexander N Shoushtari, et al.British Journal of Cancer|October 29, 2011
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control studyJ N Hofmann, A Baccarelli, K Schwartz, et al.Investigational New Drugs|May 13, 2010
A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumorsMark Andrew Dickson, Dana E Rathkopf, Richard D Carvajal, et al.The Journal of Urology|February 7, 2001
Complexed prostate specific antigen provides significant enhancement of specificity compared with total prostate specific antigen for detecting prostate cancerM K Brawer, C D Cheli, I E Neaman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2023
A First-in-Human Phase I Study of Milademetan, an MDM2 Inhibitor, in Patients With Advanced Liposarcoma, Solid Tumors, or LymphomasMrinal M Gounder, Todd M Bauer, Gary K Schwartz, et al.Regional Anesthesia and Pain Medicine|September 26, 2025
Percutaneous analgesic device enabling both local anesthetic delivery and electrical stimulation (neuromodulation) of peripheral nerves: a pilot feasibility study (case series)Brian M Ilfeld, Engy T Said, Brian H Park, et al.Cancer|April 8, 2014
Patient-derived xenografts for individualized care in advanced sarcomaJustin Stebbing, Keren Paz, Gary K Schwartz, et al.Neoplasia (New York, N.Y.)|March 10, 2015
Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcomeJoyce N Barlin, Qin C Zhou, Mario M Leitao, et al.Human Mutation|November 26, 1998
Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathyF Tesson, P Richard, P Charron, et al.Pageof 104